MaxCyte Inc (NAS:MXCT)
$ 4.24 0.08 (1.92%) Market Cap: 436.74 Mil Enterprise Value: 293.28 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 79/100

Q3 2021 MaxCyte Inc Earnings Call Transcript

Nov 10, 2021 / 09:30PM GMT
Release Date Price: $10.7 (-7.68%)
Operator

Good day, ladies and gentlemen, and welcome to the MaxCyte Third quarter Earnings Conference Call. (Operator Instructions) Later, we will conduct a question-and-answer session, and instructions will follow at that time. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Mr. Sean Menarguez.

Sean Menarguez
MaxCyte, Inc. - Business Intelligence, Strategy & IR

Good afternoon, everyone. My name is Sean Menarguez, and I'm an analyst on the MaxCyte team. Thank you all for participating in today's conference call. On the call from MaxCyte, we have Doug Doerfler, Chief Executive Officer; and Amanda Murphy, Chief Financial Officer. Earlier today, MaxCyte released financial results for the third quarter ended September 30, 2021. A copy of the press release is available on the company's website.

Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within the meaning of federal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot